Galderma Group AG clinical trials

The registry lists 296 studies whose lead sponsor is Galderma Group AG or one of 4 companies grouped under it. 11 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 23, 2026.

Studies

Recruiting first, then most recently updated. Showing 50 of 296. Browse all 296 →

• A Study to Evaluate the Long-term Safety and Effectiveness of Sculptra™RecruitingNCT07891767

  Sponsor listed in the registry: Galderma R&D

• Randomized, Double-blind, Placebo-controlled Study of Nemolizumab in Chinese Subjects With Moderate-to-severe Atopic DermatitisRecruitingNCT07762833Phase 3

  Sponsor listed in the registry: Galderma R&D

• A Study to Evaluate the Effectiveness and Safety of Restylane Shaype in the Improvement of Jawline DefinitionNot yet recruitingNCT07805512Not applicable

  Sponsor listed in the registry: Galderma R&D

• Real-world Experience on Using Nemolizumab in the Treatment of Moderate-to- Severe Prurigo Nodularis in AdultsRecruitingNCT06988618

  Sponsor listed in the registry: Galderma R&D

• Pharmacokinetics, Safety and Efficacy of Nemolizumab in Participants Aged 6 to 23 Months With Moderate-to Severe Atopic DermatitisRecruitingNCT07660835Phase 2

  Sponsor listed in the registry: Galderma R&D

• Study to Evaluate the Safety of Retreatment With Restylane® Lyft With Lidocaine for Augmentation of the Chin RegionRecruitingNCT07566286Not applicable

  Sponsor listed in the registry: Galderma R&D

• A Study of Nemolizumab for the Treatment of Adults With Systemic SclerosisRecruitingNCT07047690Phase 2

  Sponsor listed in the registry: Galderma R&D

• Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & AdultsRecruitingNCT06988605

  Sponsor listed in the registry: Galderma R&D

• A Study to Characterize Human Skin Changes From Biostimulator Treatments Via Non-invasive ImagingRecruitingNCT07399028Not applicable

  Sponsor listed in the registry: Galderma R&D

• A Clinical Study to Assess Histological Changes From Treatment of Poly L-lactic Acid Biostimulator on Women at Various Menopausal StagesRecruitingNCT07342400Not applicable

  Sponsor listed in the registry: Galderma R&D

• Retrospective Study of the Safety and Efficacy of PLLA for Skin Flaccidity in Labia Majora and/or Pubis RegionRecruitingNCT05940038

  Sponsor listed in the registry: Galderma Brasil Ltda.

• Long-term Safety and Efficacy of Nemolizumab With Moderate-to-severe Atopic DermatitisCompletedNCT03989206Phase 3

  Sponsor listed in the registry: Galderma R&D

• A Study to Compare the Efficacy, Safety and Pharmacokinetics of Trifarotene 50 mcg/g Cream in Chinese Subjects With Acne VulgarisActive, not recruitingNCT07186413Phase 3

  Sponsor listed in the registry: Galderma R&D

• A Prospective Pilot Study to Evaluate Safety and Effectiveness of GP0122 and GP0124 for Correction of Lines and Wrinkles in the Cheek AreaActive, not recruitingNCT07344584Not applicable

  Sponsor listed in the registry: Galderma R&D

• Evaluate the Effectiveness and Safety of Restylane Volyme in the Treatment of Temple HollowingCompletedNCT06665477Not applicable

  Sponsor listed in the registry: Galderma R&D

• Proof of Concept Study to Assess the Pharmacokinetics/Pharmacodynamics of Nemolizumab in Adults With Chronic Pruritus of Unknown Origin (CPUO)Active, not recruitingNCT07074977Phase 2

  Sponsor listed in the registry: Galderma R&D

• Main Study: A Study to Evaluate the Effectiveness and Safety of GAL1906 for Correction of Wrinkles in the décolletage Area Sub-study: A Follow-up Study to Evaluate the Analysis of Mammograms Following Treatment for Correction of Wrinkles in Décolletage Area in the Investigational Study 43USRV1906CompletedNCT04717934Not applicable

  Sponsor listed in the registry: Galderma R&D

• Pharmacokinetics, Safety and Efficacy of Nemolizumab in Participants With Moderate-to-Severe Atopic DermatitisCompletedNCT04921345Phase 2

  Sponsor listed in the registry: Galderma R&D

• A Study to Evaluate the Effectiveness and Safety of Restylane Skinboosters Vital LidocaineActive, not recruitingNCT07047638Not applicable

  Sponsor listed in the registry: Galderma R&D

• Sculptra Chart ReviewCompletedNCT05463978

  Sponsor listed in the registry: Galderma R&D

• A Study to Assess Efficacy and Tolerability of Topical Skincare Products on Psoriasis PatientsCompletedNCT06357221Phase 4

  Sponsor listed in the registry: Galderma R&D

• A Study to Assess Immunization Responses in Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis Treated With NemolizumabCompletedNCT04365387Phase 2

  Sponsor listed in the registry: Galderma R&D

• Assess Aesthetic Improvement With QM1114-DP in Subjects With Moderate to Severe Lateral Canthal Lines and Glabellar LinesCompletedNCT05148000Phase 3

  Sponsor listed in the registry: Galderma R&D

• Safety and Effectiveness of Restylane Lyft With Lidocaine for Augmentation of the Chin Region to Improve the Chin ProfileCompletedNCT05777759Not applicable

  Sponsor listed in the registry: Galderma R&D

• Effectiveness and Safety of Restylane Contour in the Treatment of Temple HollowingCompletedNCT05691972Not applicable

  Sponsor listed in the registry: Galderma R&D

• To Evaluate Effectiveness and Safety of GP0109 for Jawline DefinitionCompletedNCT05110287

  Sponsor listed in the registry: Galderma R&D

• A Clinical Study to Assess the Efficacy and Safety of a Healing Ointment on Diaper RashCompletedNCT06015217Phase 4

  Sponsor listed in the registry: Galderma R&D

• Comparative Ultrasound Analysis of Two Hyaluronic Acid Dermal FillersCompletedNCT05622851Not applicable

  Sponsor listed in the registry: Galderma R&D

• To Evaluate the Efficacy and Safety of Nemolizumab for 12 Weeks in Participants With Chronic Kidney Disease With Associated Moderate to Severe PruritusCompletedNCT05075408Phase 2/3

  Sponsor listed in the registry: Galderma R&D

• Comparison of Mechanical Penetration Enhancers on Metvixia Skin PenetrationCompletedNCT02511145Phase 1

  Sponsor listed in the registry: Galderma R&D

• Evaluation of the Effects of a Biostimulator and Dermal Fillers for Cheek Augmentation and Contour DeficienciesCompletedNCT06351358Not applicable

  Sponsor listed in the registry: Galderma R&D

• Gene Expression Study Between Two Dermal Injectables Hydroxylapatite Semi-permanent FillerCompletedNCT05620043Not applicable

  Sponsor listed in the registry: Galderma R&D

• A Clinical Study to Assess Efficacy and Tolerability of a Topical Skincare Product on Adults With Mature, Crepey SkinCompletedNCT07398989Phase 4

  Sponsor listed in the registry: Galderma R&D

• A Comparative Analysis of Two Hyaluronic Acid Fillers for Nasolabial Fold CorrectionCompletedNCT06351293Not applicable

  Sponsor listed in the registry: Galderma R&D

• Safety and Effectiveness of Restylane® Kysse for Lip Augmentation in Chinese SubjectsCompletedNCT05342753Not applicable

  Sponsor listed in the registry: Galderma R&D

• A Long-term Study of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN)Active, not recruitingNCT04204616Phase 3

  Sponsor listed in the registry: Galderma R&D

• Comparing Pain, Safety and Effectiveness of Restylane Skinboosters Vital Lido and Vital Without Lido in Dorsal HandCompletedNCT06372782Not applicable

  Sponsor listed in the registry: Galderma R&D

• Non-interventional Study, Long Term Treatment on Glabellar Lines With Dysport® in Subjects of Chinese OriginCompletedNCT05089357

  Sponsor listed in the registry: Galderma R&D

• Study to Evaluate the Safety and Effectiveness of GP0116Active, not recruitingNCT05987163Not applicable

  Sponsor listed in the registry: Galderma R&D

• Open Label Extension for 43USSA1812CompletedNCT04595331Not applicable

  Sponsor listed in the registry: Galderma R&D

• Healing Ointment Usage Post-surgical ProcedureCompletedNCT05686928Phase 4

  Sponsor listed in the registry: Galderma R&D

• Photodynamic Therapy (PDT) With Metvix® 160 Milligrams/Gram Cream in Organ Transplant Participants With Non-melanoma Skin CancerCompletedNCT00472459Phase 3

  Sponsor listed in the registry: Galderma R&D

• Extension Study for 43USSA1705CompletedNCT04225273Not applicable

  Sponsor listed in the registry: Galderma R&D

• Effectiveness and Safety of Restylane Lyft Lidocaine for Jawline DefinitionCompletedNCT05622812Not applicable

  Sponsor listed in the registry: Galderma R&D

• A Restylane Treatment Algorithm Approach for Participants With Appearance of Insufficient Bone Structure in the Lower Face Alone or in Combination With Facial Soft Tissue DeficienciesCompletedNCT06428214Not applicable

  Sponsor listed in the registry: Galderma R&D

• Sculptra for Correction of Midface Volume Deficit and/or Midface Contour DeficiencyCompletedNCT04132518Not applicable

  Sponsor listed in the registry: Galderma R&D

• Study to Access the Relative Bioavailability of Subcutaneous Dose of Nemolizumab When Administered Via Auto-Injector Versus Dual-Chamber SyringeCompletedNCT05405985Phase 1

  Sponsor listed in the registry: Galderma R&D

• A Study to Assess the Effects of Nemolizumab on Cytochrome P450 Substrates in Participants With Moderate-to-Severe Atopic DermatitisCompletedNCT04562116Phase 2

  Sponsor listed in the registry: Galderma R&D

• A Study to Evaluate the Effects for Midface Improvement When Pairing a Biostimulator with a Skincare RegimenCompletedNCT05963204Not applicable

  Sponsor listed in the registry: Galderma R&D

• Assess Aesthetic Improvement and Onset of QM1114-DP in Subjects With Moderate to Severe Glabellar LinesCompletedNCT05146999Phase 3

  Sponsor listed in the registry: Galderma R&D